Enhancement by thyroid hormone treatment of norepinephrine-induced phosphorylase activation in the rat heart.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004789:Enzyme Activation; D005964:Glucosyltransferases / Q000378:metabolism*; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006980:Hyperthyroidism / Q000139:chemically induced / Q000201:enzymology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D010725:Phosphocreatine / Q000378:metabolism; D006005:Phosphorylases / Q000378:metabolism; D011868:Radioisotopes; D051381:Rats; D012413:Rubidium / Q000378:metabolism; D013696:Temperature; D014284:Triiodothyronine / Q000378:metabolism / Q000494:pharmacology*; D014316:Tritium
D011868:Radioisotopes; D010725:Phosphocreatine; D014284:Triiodothyronine; D014316:Tritium; D000255:Adenosine Triphosphate; D005964:Glucosyltransferases; D006005:Phosphorylases; D012413:Rubidium; D009638:Norepinephrine